Literature DB >> 19345967

Ethical considerations of clinical trials in the developing world.

Joseph R Fitchett1.   

Abstract

The developing world is entering new territory with rapid advancements in biomedical research and science. In order to ensure the protection of those most vulnerable, bioethics must experience a similar expansion and progression worldwide. Inequalities in healthcare remain an influential issue to redress on a global scale, and may provide an opportunity to induce a paradigm shift in the worldwide approach to medical research. In particular, clinical trials performed in a nation different to that of the sponsoring institution must appreciate any underlying ethical conflict and ensure that the volunteers involved are treated with the best attainable and sustainable standards.

Mesh:

Year:  2009        PMID: 19345967     DOI: 10.1016/j.trstmh.2009.02.021

Source DB:  PubMed          Journal:  Trans R Soc Trop Med Hyg        ISSN: 0035-9203            Impact factor:   2.184


  2 in total

1.  The impact of clinical research activities on communities in rural Africa: the development of the Clinical Research Unit of Nanoro (CRUN) in Burkina Faso.

Authors:  Halidou Tinto; Innocent Valea; Hermann Sorgho; Marc Christian Tahita; Maminata Traore; Biébo Bihoun; Issa Guiraud; Hervé Kpoda; Jérémi Rouamba; Sayouba Ouédraogo; Palpouguini Lompo; Sandrine Yara; William Kabore; Jean-Bosco Ouédraogo; Robert Tinga Guiguemdé; Fred N Binka; Bernhards Ogutu
Journal:  Malar J       Date:  2014-03-22       Impact factor: 2.979

2.  High adherence level to artemisinin-based combination therapies in rural settlement 11 years after their introduction in the health system, Nanoro, Burkina Faso.

Authors:  Toussaint Rouamba; Paul Sondo; Isidore W Yerbanga; Adelaide Compaore; Maminata Traore-Coulibaly; Franck S Hien; Nassirou A Diande; Daniel Valia; Innocent Valea; Patricia Akweongo; Rita Baiden; Fred Binka; Fati Kirakoya-Samadoulougou; Halidou Tinto
Journal:  Patient Prefer Adherence       Date:  2019-02-28       Impact factor: 2.711

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.